FDA Selects Workflow Services as Diagnostic Data Program Partner for Point-of-Care Testing Inside Pharmacies

MADISON, Wis. – November 29, 2023 – Workflow Services, an automated platform that solves point-of-care clinical service delivery for pharmacies, was selected by the Food and Drug Administration (FDA) as a premier partner in its Diagnostic Data Program, launched to collect data from point-of-care tests (POCT) administered nationally in pharmacy settings.   

The FDA Program’s aim of de-identified data collection and transmission will aid federal and state public health leaders in making evidence-based decisions from a regulatory as well as population health standpoint. In 2021, Workflow Solutions was a top-five data reporter to the CDC on COVID-19 test results.

Kevin Houlihan, President and CEO of Workflow Services and ImageMover, said about the partnership, “We are passionate about removing barriers to service delivery in pharmacy—and data collection and transmission are integral to that, particularly as they apply to population health. We are proud to partner with the FDA and look forward to working together to drive further innovation and usher in new technological ways of accessing point-of-care tests and using diagnostic data for years to come.”

Learn more here about Workflow Services' partnership with the FDA, where you can sign up for regular updates.  

View the full press release here.